An activatable, carrier-free, triple-combination nanomedicine for ALK/EGFR-mutant non-small cell lung cancer highly permeable targeted chemotherapy

作者：Zhonglei Wang, Liyan Yang, Yake Li, Shaohua Song, Juan Qu, Rui He, Shanshan Ren, Peiwei Gong · 发表于：New Journal of Chemistry · 年份：2022 · DOI：10.1039/d2nj03231g · 被引用次数：11 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Peptidase Inhibition and Analysis

Highly permeable targeted chemotherapy is highly desired for treating non-small cell lung cancer (NSCLC).